{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:36:10Z","timestamp":1791866170010,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1709-6","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T11:04:24Z","timestamp":1538564664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Is synovial hypertrophy without Doppler activity sensitive to change? Post-hoc analysis from a rheumatoid arthritis ultrasound study"],"prefix":"10.1186","volume":"20","author":[{"given":"Lene","family":"Terslev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde Berner","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"issue":"4","key":"1709_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69(4):631\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1709_CR2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69(6):964\u201375.","journal-title":"Ann Rheum Dis"},{"key":"1709_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/ard.2003.007062","volume":"63","author":"RJ Wakefield","year":"2004","unstructured":"Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW, McGonagle D, et al. Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis. 2004;63:382\u20135.","journal-title":"Ann Rheum Dis"},{"key":"1709_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/rheumatology\/kem286","volume":"47","author":"F Salaffi","year":"2008","unstructured":"Salaffi F, Filippucci E, Carotti M, Naredo E, Meenagh G, Ciapetti A, et al. Inter-observer agreement of standard joint counts in early rheumatoid arthritis: a comparison with grey scale ultrasonography\u2014a preliminary study. Rheumatology (Oxford). 2008;47:54\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"1709_CR5","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology \/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"1709_CR6","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1136\/ard.60.7.690","volume":"60","author":"E Qvistgaard","year":"2001","unstructured":"Qvistgaard E, Rogind H, Torp-Pedersen S, Terslev L, Danneskiold-Sams\u00f8e B, Bliddal H. Quantitative ultrasonography in rheumatoid arthritis: evaluation of inflammation by Doppler technique. Ann Rheum Dis. 2001;60:690\u20133.","journal-title":"Ann Rheum Dis"},{"key":"1709_CR7","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/art.10877","volume":"48","author":"M Szkudlarek","year":"2003","unstructured":"Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, \u00d8stergaard M. Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum. 2003;48:955\u201362.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1709_CR8","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1136\/ard.2011.152926","volume":"70","author":"HB Hammer","year":"2011","unstructured":"Hammer HB, Bolton-King P, Bakkeheim V, Berg TH, Sundt E, Kongtorp AK, et al. Examination of intra and interrater reliability with a new ultrasonographic reference atlas for scoring of synovitis in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70(11):1995\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1709_CR9","doi-asserted-by":"publisher","first-page":"e000428","DOI":"10.1136\/rmdopen-2016-000428","volume":"3","author":"MA D'Agostino","year":"2017","unstructured":"D'Agostino MA, Terslev L, Aegerter P, Backhaus M, Balint P, Bruyn GA, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-part 1: definition and development of a standardised, consensus-based scoring system. RMD Open. 2017;3(1):e000428.","journal-title":"RMD Open."},{"issue":"12","key":"1709_CR10","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.3899\/jrheum.100322","volume":"37","author":"MJ Larch\u00e9","year":"2010","unstructured":"Larch\u00e9 MJ, Seymour M, Lim A, Eckersley RJ, P\u00e9tavy F, et al. Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroids. J Rheumatol. 2010;37(12):2493\u2013501.","journal-title":"J Rheumatol"},{"issue":"4","key":"1709_CR11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/art.20123","volume":"50","author":"PC Taylor","year":"2004","unstructured":"Taylor PC, Steuer A, Gruber J, Cosgrove DO, Blomley MJ, Marsters PA, et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum. 2004;50(4):1107\u201316.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1709_CR12","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1002\/art.22190","volume":"54","author":"AK Brown","year":"2006","unstructured":"Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 2006;54(12):3761\u201373.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1709_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/annrheumdis-2015-208941","volume":"75","author":"J Dale","year":"2016","unstructured":"Dale J, Stirling A, Zhang R, Purves D, Foley J, Sambrook M, et al. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Ann Rheum Dis. 2016;75(6):1043\u201350.","journal-title":"Ann Rheum Dis"},{"key":"1709_CR14","doi-asserted-by":"publisher","first-page":"i4205","DOI":"10.1136\/bmj.i4205","volume":"354","author":"EA Haavardsholm","year":"2016","unstructured":"Haavardsholm EA, Aga AB, Olsen IC, Lillegraven S, Hammer HB, Uhlig T, et al. Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial. BMJ. 2016;354:i4205.","journal-title":"BMJ"},{"issue":"8","key":"1709_CR15","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/art.23097","volume":"57","author":"RJ Wakefield","year":"2007","unstructured":"Wakefield RJ, Freeston JE, Hensor EM, Bryer D, Quinn MA, Emery P. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis. Arthritis Rheum. 2007;57(8):1564\u20137.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1709_CR16","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1136\/ard.2005.044628","volume":"65","author":"E Filippucci","year":"2006","unstructured":"Filippucci E, Iagnocco A, Salaffi F, Cerioni A, Valesini G, Grassi W. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Ann Rheum Dis. 2006;65(11):1433\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1709_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/ard.62.2.178","volume":"62","author":"L Terslev","year":"2003","unstructured":"Terslev L, Torp-Pedersen S, Qvistgaard E, Kristoffersen H, R\u00f8gind H, Danneskiold-Sams\u00f8e B, et al. Effects of treatment with etanercept (Enbrel, TNRF:fc) on rheumatoid arthritis evaluated by Doppler ultrasonography. Ann Rheum Dis. 2003;62(2):178\u201381.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1709_CR18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/art.37954","volume":"65","author":"M Witt","year":"2013","unstructured":"Witt M, Mueller F, Nigg A, Reindl C, Leipe J, Proft F, et al. Relevance of grade 1 gray-scale ultrasound findings in wrists and small joints to the assessment of subclinical synovitis in rheumatoid arthritis. Arthritis Rheum. 2013;65(7):1694\u2013701.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1709_CR19","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1002\/art.23945","volume":"58","author":"AK Brown","year":"2008","unstructured":"Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58(10):2958\u201367.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1709_CR20","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/art.24596","volume":"60","author":"B Saleem","year":"2009","unstructured":"Saleem B, Brown AK, Keen H, Nizam S, Freeston J, Karim Z, et al. Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: a clinical and imaging comparative study. Arthritis Rheum. 2009;60(7):1915\u201322.","journal-title":"Arthritis Rheum"},{"key":"1709_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1709_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/ard.2007.078451","volume":"67","author":"ST Torp-Pedersen","year":"2008","unstructured":"Torp-Pedersen ST, Terslev L. Settings and artefacts relevant in colour\/power Doppler ultrasound in rheumatology. Ann Rheum Dis. 2008;67(2):143\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1709_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/acr.23339","volume":"70","author":"Hilde B. Hammer","year":"2018","unstructured":"Hammer HB, Uhlig T, Kvien TK, Lampa J. Pain catastrophizing is strongly associated with subjective outcomes, but not with inflammatory assessments in rheumatoid arthritis patients. Arthritis Care Res (Hoboken). 2018;70(5):703\u201312.","journal-title":"Arthritis Care & Research"},{"issue":"2","key":"1709_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/ard.2009.123729","volume":"70","author":"UM D\u00f8hn","year":"2011","unstructured":"D\u00f8hn UM, Ejbjerg B, Boonen A, Hetland ML, Hansen MS, Knudsen LS, et al. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study. Ann Rheum Dis. 2011;70(2):252\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1709_CR25","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1136\/annrheumdis-2015-207709","volume":"75","author":"MA D\u2019Agostino","year":"2016","unstructured":"D\u2019Agostino MA, Wakefield RJ, Berner-Hammer H, Vittecoq O, Filippou G, Balint P, Iagnocco A, Naredo E, \u00d8stergaard M, Boers M, Gaillez C, van Holder K, Le Bars M, OMERACT-EULAR Ultrasound task force. Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study. Ann Rheum Dis. 2016;75(10):1763\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1709_CR26","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1136\/annrheumdis-2015-208103","volume":"75","author":"I Padovano","year":"2016","unstructured":"Padovano I, Costantino F, Breban M, D'Agostino MA. Prevalence of ultrasound synovial inflammatory findings in healthy subjects. Ann Rheum Dis. 2016;75(10):1819\u201323.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1709_CR27","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/rheumatology\/kew317","volume":"55","author":"M Ammitzb\u00f8ll-Danielsen","year":"2016","unstructured":"Ammitzb\u00f8ll-Danielsen M, \u00d8stergaard M, Naredo E, Terslev L. Validity and sensitivity to change of the semi-quantitative OMERACT ultrasound scoring system for tenosynovitis in patients with rheumatoid arthritis. Rheumatology (Oxford). 2016;55(12):2156\u201366.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1709_CR28","doi-asserted-by":"publisher","first-page":"e000427","DOI":"10.1136\/rmdopen-2016-000427","volume":"3","author":"L Terslev","year":"2017","unstructured":"Terslev L, Naredo E, Aegerter P, Wakefield RJ, Backhaus M, Balint P, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-part 2: reliability and application to multiple joints of a standardised consensus-based scoring system. RMD Open. 2017;3(1):e000427.","journal-title":"RMD Open"},{"issue":"2","key":"1709_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/art.38940","volume":"67","author":"S Torp-Pedersen","year":"2015","unstructured":"Torp-Pedersen S, Christensen R, Szkudlarek M, Ellegaard K, D'Agostino MA, Iagnocco A, et al. Power and color Doppler ultrasound settings for inflammatory flow: impact on scoring of disease activity in patients with rheumatoid arthritis. Arthritis Rheumatol. 2015;67(2):386\u201395.","journal-title":"Arthritis Rheumatol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1709-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1709-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1709-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T19:16:12Z","timestamp":1570043772000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1709-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1709"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1709-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734157892.793561029","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]},"assertion":[{"value":"7 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Regional Committee for Medical and Health Research Ethics, South-East Norway, and all patients gave written consent according to the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LT declares speakers fees from Roche, MSD, BMS, Pfizer, AbbVie, Novartis, and Janssen. MO declares research support and\/or consultancy\/speaker fees from Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Centocor, GSK, Hospira, Janssen, Merck, Mundipharma, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Takeda, UCB, and Wyeth. HBH declares study grants from AbbVie\/Pfizer and Roche. JS declares that he has no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"224"}}